⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL181355 | 0.97 | — | — | |
| SCHEMBL25682240 | 0.90 | MCL1 (0.41) | — | |
| SCHEMBL4075839 | 0.79 | NPC1 (0.37) | — | |
| SCHEMBL499584 | 0.79 | — | — | |
| Pyrene SCHEMBL28026667 | 0.78 | KDM4E (0.47) | — | |
| SCHEMBL13194213 | 0.78 | — | — | |
| SCHEMBL10050997 | 0.78 | — | — | |
| SCHEMBL5909428 | 0.78 | MCL1 (0.55) | — | |
| SCHEMBL18519236 | 0.76 | MEN1 (0.61) | — | |
| SCHEMBL134099 | 0.75 | ALDH1A1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250306032-A1 | METHODS FOR IDENTIFYING REACTIVE FUNCTIONAL CYSTEINES IN NUCLEAR PROTEINS | TALUS BIOSCIENCE, INC. | 2025-10-02 | — | — | US | disclosed |
| EP-4526686-A1 | METHODS FOR IDENTIFYING REACTIVE FUNCTIONAL CYSTEINES IN NUCLEAR PROTEINS | Talus Bioscience, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| CN-110179974-B | Vaccine | 葛兰素史密丝克莱恩生物有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20230405104-A1 | PROTEOGLYCAN CONJUGATE AND APPLICATION THEREOF | SHANGHAI REINOVAX BIOLOGICS CO., LTD (CN) | 2023-12-21 | — | — | US | disclosed |
| WO-2023225568-A1 | METHODS FOR IDENTIFYING REACTIVE FUNCTIONAL CYSTEINES IN NUCLEAR PROTEINS | TALUS BIOSCIENCE, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| US-20230270876-A1 | SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES | NOVARTIS AG (CH) | 2023-08-31 | — | — | US | disclosed |
| EP-4234572-A1 | PROTEOGLYCAN CONJUGATE AND APPLICATION THEREOF | Shanghai Reinovax Biologics Co., Ltd (CN) | 2023-08-30 | — | — | EP | disclosed |
| CN-116507359-A | Protein polysaccharide conjugate and application thereof | 上海瑞宙生物科技有限公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20220143166-A1 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE | BIOLOGICAL E LIMITED (IN) | 2022-05-12 | — | — | US | disclosed |
| WO-2021214179-A2 | SYNTHETIC STREPTOCOCCUS PNEUMONIAE SACCHARIDE CONJUGATES TO CONSERVED MEMBRANE PROTEIN | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-10-28 | — | — | WO | disclosed |
| EP-1968631-A2 | VACCINE | GlaxoSmithKline Biologicals S.A. (BE) | 2008-09-17 | — | — | EP | disclosed |
| EP-1962899-A2 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE | GlaxoSmithKline Biologicals S.A. (BE) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007116028-A2 | CONJUGATE VACCINES | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007071710-A2 | VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2007-06-28 | — | — | WO | disclosed |
| WO-2007071711-A2 | VACCINE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2007-06-28 | — | — | WO | disclosed |
| WO-2007071707-A2 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2007-06-28 | — | — | WO | disclosed |
| US-7052916-B2 | Polypeptide analyses using stable isotope labeling | IMMUNEX CORPORATION (US) | 2006-05-30 | — | — | US | disclosed |
| US-20030219838-A1 | Polypeptide analyses using stable isotope labeling | IMMUNEX CORPORATION | 2003-11-27 | — | — | US | disclosed |
| US-20030108959-A1 | Treating diseases mediated by metalloprotease-shed proteins | IMMUNEX CORPORATION | 2003-06-12 | — | — | US | disclosed |
| WO-2003036264-A2 | TREATING DISEASES MEDIATED BY METALLOPROTEASE-SHED PROTEINS | IMMUNEX CORPORATION (US) | 2003-05-01 | — | — | WO | disclosed |